Seek Returns

BMY vs. IQV: Bristol-Myers Squibb vs. IQVIA Stock Comparison

How do Bristol-Myers Squibb (BMY) and IQVIA (IQV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Bristol-Myers Squibb (BMY) and IQVIA (IQV) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but BMY is classified in Pharmaceuticals while IQV is classified in Life Sciences Tools & Services.

Company profile comparison for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
Profile ItemBMYIQV
NameBristol-Myers Squibb CompanyIQVIA Holdings Inc.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticalsLife Sciences Tools & Services
GICS Sub-IndustryPharmaceuticalsLife Sciences Tools & Services
Market Capitalization127.02 billion USD44.80 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateJune 1, 1972May 9, 2013
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

BMY
IQV
GSPC
Loading price history…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Bristol-Myers Squibb (BMY) and IQVIA (IQV). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Bristol-Myers Squibb (BMY) and IQVIA (IQV). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
Total Return (1Y)38.62%32.11%
Total Return (3Y, Annualized)12.29%13.15%
Total Return (5Y, Annualized)5.09%2.00%

Risk Profile

Drawdown History

BMY
IQV
GSPC
Loading price history…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Bristol-Myers Squibb (BMY) and IQVIA (IQV). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
Volatility (1Y, Annualized)28.01%40.77%
Beta (5Y)0.191.14
Max Drawdown (5Y)-47.67%-51.52%
Avg. Volume (3M)10.85M1.40M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
BMY and IQV are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
Sharpe Ratio (1Y)1.230.68
Sortino Ratio (1Y)1.951.03

Profitability

ROE (TTM)

Both Bristol-Myers Squibb (BMY) at 44.01% and IQVIA (IQV) at 21.39% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

44.01%

Max
109.18%
BMY
44.01%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.39%

Max
109.18%
IQV
21.39%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Bristol-Myers Squibb (BMY) at 18.47% keeps the most of each sales dollar — above its industry’s net margin range — and IQVIA (IQV) at 8.05% also retains a top-quartile share.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.47%

BMY
18.47%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.05%

Max
18.05%
IQV
8.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Bristol-Myers Squibb (BMY) at 33.79% operates in the top operating margin quartile, ahead of IQVIA (IQV) at 13.73%, which runs around its industry’s norm.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.79%

Max
83.12%
BMY
33.79%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.73%

Max
83.12%
Q3
14.77%
IQV
13.73%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
ROE (TTM)44.01%21.39%
ROA (TTM)10.90%5.08%
Net Margin (TTM)18.47%8.05%
Operating Margin (TTM)33.79%13.73%
Gross Margin (TTM)70.50%33.07%

Growth

Revenue Growth

Both Bristol-Myers Squibb (BMY) at -0.22% and IQVIA (IQV) at 5.87% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: IQVIA (IQV) reports EPS growth of 4.67%, ranked against its industry; Bristol-Myers Squibb (BMY) has no EPS growth figure this period.

Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
Revenue Growth (YoY)-0.22%5.87%
Revenue Growth (3Y CAGR)1.45%4.21%
EPS Growth (YoY)--4.67%
EPS Growth (3Y CAGR)5.46%11.08%

Financial Strength

Current Ratio (MRQ)

Both Bristol-Myers Squibb (BMY) at 1.59 and IQVIA (IQV) at 0.83 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.59

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
BMY
1.59
Min
0.10

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.83

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
IQV
0.83
Min
0.10
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Debt sits unusually high against shareholders’ equity for both Bristol-Myers Squibb (BMY) at 1.91 and IQVIA (IQV) at 2.40 — each debt-to-equity ratio is above its industry benchmark range.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.91

BMY
1.91
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40

IQV
2.40
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
Current Ratio (MRQ)1.590.83
Debt / Equity (MRQ)1.912.40
Net Debt / EBITDA1.774.46

Dividends

Dividend Yield (TTM)

IQVIA (IQV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Bristol-Myers Squibb (BMY) reports a yield of 3.99%, ranking against industry peers normally.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.99%

BMY
3.99%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

IQVIA (IQV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Bristol-Myers Squibb (BMY) reports a payout of 55.88%, ranking against industry peers normally.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

55.88%

BMY
55.88%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
Dividend Yield (TTM)3.99%0.00%
Dividend Payout Ratio (TTM)55.88%0.00%

Valuation

P/E Ratio (TTM)

Both Bristol-Myers Squibb (BMY) at 13.78 and IQVIA (IQV) at 33.07 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.78

Max
85.34
Q3
43.46
Median
26.69
BMY
13.78
Q1
13.30
Min
0.07

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.07

Max
85.34
Q3
43.46
IQV
33.07
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

Both Bristol-Myers Squibb (BMY) at 2.54 and IQVIA (IQV) at 2.59 fetch a relatively low price per dollar of sales, landing in the cheaper P/S ratio quartile of their industries.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.54

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
BMY
2.54
Min
0.01

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.59

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
IQV
2.59
Min
0.01
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Bristol-Myers Squibb (BMY) at 5.43 is valued about in line with its industry on P/B ratio, while IQVIA (IQV) at 6.73 carries an above-peer premium to book — IQV is pricier on assets.

BMY

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.43

Max
13.53
Q3
6.54
BMY
5.43
Median
3.25
Q1
1.69
Min
-5.59

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.73

Max
13.53
IQV
6.73
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Bristol-Myers Squibb (BMY) vs. IQVIA (IQV): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Bristol-Myers Squibb (BMY) and IQVIA (IQV)
MetricBMYIQV
P/E Ratio (TTM)13.7833.07
P/S Ratio (TTM)2.542.59
P/B Ratio (MRQ)5.436.73
Free Cash Flow Yield (TTM)5.01%4.72%